
Keywords: AASLD; the American Association for the Study of Liver Diseases; EASL; European Association for the Study of the Liver; HE; hepatic encephalopathy; LOLA; L-ornithine L-aspartate; WHC; West Haven criteria; Hepatic encephalopathy; Rifaximin; Metronidazole;